Read article Thomas Aversano.2012-03-24
Protección gástrica en pacientes sometidos a angioplastia coronaria
Gastón Dussaillant 2011-08-03
Angioplastia de Tronco de la Coronaria izquierda Racionalidad y Evidencia
Fernando Cura2014-10-30 Jefe de Cardiología Intervencionista y Terapéuticas Endovasculares ICBA – Argentina
Angioplastia Transluminal Coronaria Compleja por Acceso Radial
Mauricio G. Cohen2014-08-07 MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine
Angioplastia Coronaria
Erick Hórnez2013-11-21
ASCERT: Cirugia versus angioplastia en pacientes añosos con enfermedad coronaria de múltiples vasos: comparación de dos registros norteamericanos.
Editorial Read article William Weintraub.2012-03-26
Long-term Results of Coronary Bifurcation Lesion Treatment in Diabetic Patients
The effects of diabetes on patients with coronary artery disease are well-known, and their outcomes after angioplasty are less favorable, with a higher rate of restenosis, recurrent acute myocardial infarction, and stent thrombosis. Despite advances in drug-eluting stents and procedural techniques, the treatment of coronary bifurcation lesions in diabetic patients shows less positive clinical outcomes...
AHA 2023 | SELECT Trial: Semaglutide in Patients Without Diabetes
Given the obesity pandemic projected for the year 2035, it is imperative to address this disease as a priority, through well-known hygienic-dietary measures and the use of drugs that have shown promising results. Obesity has been identified as an independent cardiovascular risk factor, even after modifying risk factors associated with diabetes. Semaglutide, a GLP-1 agonist,...
AHA 2023 | ORBITA-2: PCI vs. Placebo in Stable Angina for Symptom Reduction
In patients with stable chronic angina, percutaneous coronary intervention (PCI) is often conducted to relieve symptoms. However, there is still some uncertainty regarding whether PCI provides superior symptomatic relief compared with a placebo in patients not receiving anti-anginal medication. Researchers conducted a controlled and randomized study in which patients with stable angina discontinued all anti-anginal...
AHA 2023 | Use of Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Subclinical atrial fibrillation (AF), generally asymptomatic and of short duration, often requires continuous long-term monitoring using pacemakers or defibrillators for its detection. While subclinical AF is linked to an increased risk of stroke, the usefulness of oral anticoagulation as a treatment remains uncertain. In a double-blind randomized trial, one group received apixaban and the other...